UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGMENT CO Buys 1, Sells 4 in 2nd Quarter

UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGMENT CO recently filed their 13F report for the second quarter of 2022, which ended on 2022-06-30.

The 13F report details which stocks were in a guru’s equity portfolio at the end of the quarter, though investors should note that these filings are limited in scope, containing only a snapshot of long positions in U.S.-listed stocks and American depository receipts as of the quarter’s end. They are not required to include international holdings, short positions or other types of investments. Still, even this limited filing can provide valuable information.

210 W. 7TH STREET, SUITE 1700 AUSTIN, TX 78701

As of the latest 13F report, the guru’s equity portfolio contained 17 stocks valued at a total of $231.00Mil. The top holdings were BBRE(82.65%), EOCW.U(8.48%), and IMTX(2.63%).

According to GuruFocus data, these were UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGMENT CO’s top five trades of the quarter.

JPMorgan BetaBuilders MSCI U.S. REIT ETF


During the quarter, UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGMENT CO bought 558,838 shares of BATS:BBRE for a total holding of 1,422,838. The trade had a 30.62% impact on the equity portfolio. During the quarter, the stock traded for an average price of $102.84.

On 08/05/2022, JPMorgan BetaBuilders MSCI U.S. REIT ETF traded for a price of $93.44 per share and a market cap of $1.02Bil. The stock has returned -4.63% over the past year.

There is insufficient data to calculate the stock’s financial strength and profitability ratings.

In terms of valuation, JPMorgan BetaBuilders MSCI U.S. REIT ETF has a price-earnings ratio of 27.45 and a price-book ratio of 2.20.

Doximity Inc


The guru sold out of their 659,891-share investment in NYSE:DOCS. Previously, the stock had a 15.02% weight in the equity portfolio. Shares traded for an average price of $50.37 during the quarter.

On 08/05/2022, Doximity Inc traded for a price of $40.31 per share and a market cap of $7.80Bil. The stock has returned -28.72% over the past year.

GuruFocus gives the company a financial strength rating of 9 out of 10 and a profitability rating of 5 out of 10.

In terms of valuation, Doximity Inc has a price-earnings ratio of 58.13, a price-book ratio of 8.77, a EV-to-Ebitda ratio of 58.73 and a price-sales ratio of 21.30.

Taysha Gene Therapies Inc


The guru sold out of their 1,147,040-share investment in NAS:TSHA. Previously, the stock had a 6.07% weight in the equity portfolio. Shares traded for an average price of $7.49 during the quarter.

On 08/05/2022, Taysha Gene Therapies Inc traded for a price of $4.28 per share and a market cap of $173.54Mil. The stock has returned -75.72% over the past year.

GuruFocus gives the company a financial strength rating of 6 out of 10 and a profitability rating of 1 out of 10.

In terms of valuation, Taysha Gene Therapies Inc has a price-book ratio of 3.25 and a EV-to-Ebitda ratio of -0.71.

Vir Biotechnology Inc


The guru sold out of their 290,736-share investment in NAS:VIR. Previously, the stock had a 5.53% weight in the equity portfolio. Shares traded for an average price of $29.81 during the quarter.

On 08/05/2022, Vir Biotechnology Inc traded for a price of $29.25 per share and a market cap of $3.87Bil. The stock has returned -21.16% over the past year.

GuruFocus gives the company a financial strength rating of 7 out of 10 and a profitability rating of 2 out of 10.

In terms of valuation, Vir Biotechnology Inc has a price-earnings ratio of 3.09, a price-book ratio of 1.85, a EV-to-Ebitda ratio of 1.60 and a price-sales ratio of 1.64.

The price-to-GF Value ratio is 0.03, earning the stock a GF Value rank of 2.

Vanguard Total World Stock ETF


UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGMENT CO reduced their investment in ARCA:VT by 52,655 shares. The trade had a 2.57% impact on the equity portfolio. During the quarter, the stock traded for an average price of $101.06.

On 08/05/2022, Vanguard Total World Stock ETF traded for a price of $91.59 per share and a market cap of $23.61Bil. The stock has returned -10.70% over the past year.

There is insufficient data to calculate the stock’s financial strength and profitability ratings.

In terms of valuation, Vanguard Total World Stock ETF has a price-earnings ratio of 14.62 and a price-book ratio of 2.19.


Please note, the numbers and facts quoted are as of the writing of this article and may not factor in the latest trading data or company announcements.

Want to provide feedback on this article? Have questions or concerns? Get in touch with us here, or email us at [email protected]!

This article is general in nature and does not represent the opinions of GuruFocus or any of its affiliates. This article is not intended to be financial advice, nor does it constitute investment advice or recommendations. It was written without regard to your individual situation or financial goals. We aim to bring you fundamental, data-driven analysis, The information on this site is in no way guaranteed for completeness, accuracy or in any other way.